Evidence map›Paper›PMID 20158558›Full record

ArticleJournal of the American Geriatrics Society2010

Homocysteine and mobility in older adults.

Lydia Rolita, Roee Holtzer, Cuiling Wang, Richard B Lipton, Carol A Derby, Joe Verghese

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Elevated Blood Homocysteine Increases the Risk of Incident Motoric Cognitive Risk Syndrome: A Two-Cohort Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Relationship between Homocysteine and Muscle Strength Decline: The Baltimore Longitudinal Study of Aging.The journals of gerontology. Series A, Biological sciences and medical sciences · 2018
    Article
  11. Article
  12. Article
  13. Vitamin B12, folic acid, and bone.Current osteoporosis reports · 2013
    Review
  14. Article
  15. Article
  16. Racial differences in gait velocity in an urban elderly cohort.Journal of the American Geriatrics Society · 2012
    Article
  17. Article
  18. Article
  19. Inflammatory markers and gait speed decline in older adults.The journals of gerontology. Series A, Biological sciences and medical sciences · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lydia RolitaDepartment of General Internal Medicine, New York University School of Medicine, New York, New York 10461, USA.
Roee Holtzer
Cuiling Wang
Richard B Lipton
Carol A Derby
Joe Verghese
Albert Einstein College of Medicine · USNew York University · US

Funding

Vascular Structure and Function in Cognitive AgingP01AG003949 · NIA · YESHIVA UNIVERSITY · PI STEVEN SUEY-MING CHIN · 1985 to 2026
$73.9M
Latent Mobility Abnormalities And FrailtyR01AG025119 · NIA · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI VERGHESE, JOE · 2005 to 2009
$1.5M
Predictors of Gait and Falls in Aging: Linking Cognitive Control to GenesK23AG030857 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI HOLTZER, ROEE · 2007 to 2011
$841k
NIA NIH HHS K23 AG030857NIA NIH HHS P01 AG003949NIA NIH HHS R01 AG025119NIA NIH HHS R01 AG03949
6 · The paper itself

Abstract

objectivesTo determine the influence of homocysteine on mobility decline in older adults.

designProspective cohort.

settingEinstein Aging Study, community-based aging study.

participantsFive hundred seventy-four older adults without dementia (mean age 80.2 +/- 5.4, 61% women). MEASUREMENTS: Mobility decline defined using gait velocity measurements at baseline and annual follow-up visits. Linear mixed effects models were used to adjust for age, sex, education, and other potential confounders.

resultsHigher homocysteine levels were associated with slower gait velocity at baseline. Adjusted for age, sex, and education, a one-unit increase in baseline log homocysteine levels was associated with a 2.95-cm/s faster mobility decline per year (P=.01) over a median follow-up of 1.4 years. The 140 subjects in the highest quartile of homocysteine had a faster rate of mobility decline (1.75 cm/s per year faster, P=.01) than the 434 subjects in the lowest three quartiles of homocysteine (<or=15 micromol/L). The association between homocysteine and mobility decline remained robust even after adjusting for multiple confounders and accounting for the presence of clinical gait abnormalities.

conclusionHigher homocysteine levels are associated with greater risk of mobility decline in community-residing older adults.

Indexed as

GaitMobility LimitationAgedAged, 80 and overBiomarkersFemaleHomocysteineHumansLinear ModelsMaleProportional Hazards ModelsProspective StudiesRisk FactorsBiomarkersHomocysteine

Identifiers

PMID20158558
PMCPMC2915401
OpenAlexW1557617397

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.